Advancing Stress Urinary Incontinence Treatment
Homogenous hydrogel consisting of 97.5% water and 2.5% cross-linked polyacrylamide.1
Allows for reproducible placement of the Bulkamid cushions under direct vision.
92% of women report being cured or improved at 12 months2, with durability demonstrated at seven years3 and no serious adverse events.
In a head-to-head RCT2 evaluating Bulkamid versus TVT (tension-free vaginal tape) in 224 women with SUI, Bulkamid demonstrated excellent efficacy with no serious complications at 1 year.
An extremely low peri and postoperative complication rate in studies up to 7 years.
Author | Tooz-Hobson4 | Sokol5 | Pai6 | Andrews7 | Marthaler8 | Zivanovic9 | Freitas2 | Brosche3 |
---|---|---|---|---|---|---|---|---|
Year | 2012 | 2014 | 2015 | 2015 | 2015 | 2016 | 2020 | 2021 |
Patients | 135 | 229 | 256 | 38 | 122 | 60 | 108 | 388 |
Adverse Events | 0 (0 %) | 1 (0.4%)* | 0 (0 %) | 0 (0 %) | 0 (0 %) | 0 (0 %) | 0 (0 %) | 0 (0 %) |
Retention | 2 (1.4 %) | 13 (5.7%) | 1 (0.4 %) | 0 (0 %) | 1 (0.8 %) | 0 (0 %) | 3 (2.8 %) | 0 (0 %) |
Infection | 0 (0 %) | 8 (3.5%) | 4 (1.6 %) | 1 (2.6 %) | 2 (1.6 %) | 2 (3.6 %) | 0 (0 %) | 11 (3.5 %) |
Follow Up | 24 Months | 12 Months | 5 Years | 6 Months | 3 Months | 12 Months | 12 Months | 7 Years |
Patients want an experience that includes engagement in shared decision making and when given the choice, 75% of women chose Bulkamid as a primary procedure in secondary-care hospitals to treat their SUI10
If you feel Bulkamid may be an option for your patients, visit Bulkamid Academy to take the first step in your training journey or please contact your local representative here.